Patents by Inventor James Edwin Blalock

James Edwin Blalock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compound for inhibiting the influx of polymorphonuclear leukocytes (PMNs) in a tissue, its selection, pharmaceutical compositions and use
    Patent number: 7410806
    Abstract: The invention relates to a compound suitable for inhibiting the influx of polymorphonuclear leukocytes (PMNs) into a tissue involved in a chronic inflammatory disease. The compound according to the invention is capable of forming a complex with N-acetyl-Pro-Gly-Pro. The invention also relates to a method of selecting such a compound, a pharmaceutical composition and an application of the compound.
    Type: Grant
    Filed: August 22, 2005
    Date of Patent: August 12, 2008
    Assignee: Fornix Biosciences N.V.
    Inventors: Franciscus Petrus Nijkamp, Rosswell Robert Pfister, Jeffrey Lynn Haddox, James Edwin Blalock, Matteo Villain
  • Compound for inhibiting the influx of polymorphonuclear leukocytes (PMNS) in a tissue, its selection, pharmaceutical compositions and use
    Patent number: 6960565
    Abstract: The invention relates to a compound suitable for inhibiting the influx of polymorphonuclear leukocytes (PMNs) into a tissue involved in a chronic inflammatory disease. The compound according to the invention is capable of forming a complex with N-acetyl-Pro-Gly-Pro. The invention also relates to a method of selecting such a compound, a pharmaceutical composition and an application of the compound.
    Type: Grant
    Filed: November 13, 2003
    Date of Patent: November 1, 2005
    Assignee: Fornix Biosciences N.V.
    Inventors: Franciscus Petrus Nijkamp, Rosswell Robert Pfister, Jeffrey Lynn Haddox, James Edwin Blalock, Matteo Villain
  • Compound for inhibiting the influx of polymorphonuclear leukocytes (PMNS) in a tissue, its selection, pharmaceutical compositions and use
    Publication number: 20040176304
    Abstract: The invention relates to a compound suitable for inhibiting the influx of polymorphonuclear leukocytes (PMNs) into a tissue involved in a chronic inflammatory disease. The compound according to the invention is capable of forming a complex with N-acetyl-Pro-Gly-Pro. The invention also relates to a method of selecting such a compound, a pharmaceutical composition and an application of the compound.
    Type: Application
    Filed: November 13, 2003
    Publication date: September 9, 2004
    Inventors: Franciscus Petrus Nijkamp, Rosswell Robert Pfister, Jeffrey Lynn Haddox, James Edwin Blalock, Matteo Villain
  • Synthetic complementary peptides and ophthalmologic uses thereof
    Patent number: 6762166
    Abstract: The present invention is directed to a series of complementary peptides for the pro-gly-pro sequence as antagonists of polymorphonuclear leukocyte chemoattractants. Also provided are applications of such peptides for treating alkali-injuried eyes and other types of diseases.
    Type: Grant
    Filed: September 28, 2001
    Date of Patent: July 13, 2004
    Assignee: Fornix Biosciences N.V.
    Inventors: Jeffrey Lynn Haddox, Roswell Robert Pfister, James Edwin Blalock, Matteo Villain
  • Synthetic complementary peptides and ophthalmologic uses thereof
    Publication number: 20020107202
    Abstract: The present invention is directed to a series of complementary peptides for the pro-gly-pro sequence as antagonists of polymorphonuclear leukocyte chemoattractants. Also provided are applications of such peptides for treating alkali-injuried eyes and other types of diseases.
    Type: Application
    Filed: September 28, 2001
    Publication date: August 8, 2002
    Inventors: Jeffrey Lynn Haddox, Roswell Robert Pfister, James Edwin Blalock, Matteo Villain
  • Synthetic complementary peptides and ophthalmologic uses thereof
    Patent number: 6310041
    Abstract: The present invention is directed to a series of complementary peptides for the pro-gly-pro sequence as antagonists of polymorphonuclear leukocyte chemoattractants. Also provided are applications of such peptides for treating alkali-injuried eyes and other types of diseases.
    Type: Grant
    Filed: March 8, 2000
    Date of Patent: October 30, 2001
    Assignee: Fornix Biosciences N.V.
    Inventors: Jeffrey Lynn Haddox, Roswell Robert Pfister, James Edwin Blalock, Matteo Villain